Keyword: GlaxoSmithKline (GSK)
News
30.05.2012
- GlaxoSmithKline plans to launch a campaign to replace the entire board of Human Genome Sciences with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech...
News
30.05.2012
- Norway's Pronova BioPharma , which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline, has defeated a U.S. patent challenge from two generics companies. The victory over...
News
10.05.2012
- GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the...
News
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
News
23.04.2012
- AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...
News
16.04.2012
- The U.S. Supreme Court heard arguments on Monday on whether pharmaceutical companies must pay sales representatives overtime, a dispute that threatens the industry with billions of...
News
02.04.2012
- In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research...
News
22.03.2012
- GlaxoSmithKline confirmed plans on Thursday to invest more than 500 million pounds in manufacturing in Britain and said it had selected Ulverston, northern England, as the site for...
